SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹90 Cr | ₹65 Cr | ₹58 Cr | ₹54 Cr | ₹31 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUVEN PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹90 Cr |
| Mar2024 | ₹65 Cr |
| Mar2023 | ₹58 Cr |
| Mar2022 | ₹54 Cr |
| Mar2021 | ₹31 Cr |
How is Deferred Tax Assets / Liabilities of SUVEN PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹90 Cr | 39.57 | |
| Mar2024 | ₹65 Cr | 11.26 | |
| Mar2023 | ₹58 Cr | 7.22 | |
| Mar2022 | ₹54 Cr | 75.59 | |
| Mar2021 | ₹31 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹14,433.6 Cr | -2.4% | -29.1% | -63.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -2.4% |
-29.1% |
-63.3% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses